Compile Data Set for Download or QSAR
Report error Found 1730 Enz. Inhib. hit(s) with Target = 'Free fatty acid receptor 2'
TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271169(7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2R)-2-(tr...)
Affinity DataEC50:  1nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271163(7-(4-chloro-2-fluorobenzenesulfonyl)-2-methyl-4-[(...)
Affinity DataEC50:  1nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271179(7-(2-fluorobenzenesulfonyl)-N2-methyl-4-(2-methylm...)
Affinity DataEC50:  1nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271162(7-(2-fluoro-4-methoxybenzenesulfonyl)-2-methyl-4-[...)
Affinity DataEC50:  1nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271161(7-(2,3-difluorobenzenesulfonyl)-4-(2,2-dimethylmor...)
Affinity DataEC50:  1nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271111(7-(2-fluorobenzenesulfonyl)-2-methyl-4-[2-(trifluo...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271173(7-(2,5-difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271170(7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2R)-2-(tr...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271121(7-(benzenesulfonyl)-2-methyl-4-(propan-2-yloxy)-5H...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271119(7-(benzenesulfonyl)-4-(2-methylmorpholin-4-yl)-2-(...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271182(7-(2-fluorobenzenesulfonyl)-2-(methylsulfanyl)-4-[...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271165(7-(2,3-difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271164(7-(2,4-difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271115(4-(2-methylmorpholin-4-yl)-7-(phenylsulfanyl)-5H-p...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271098(7-(benzenesulfonyl)-4-[(2R,5R)-2,5-dimethylmorphol...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271177(7-(4-chloro-2-fluorobenzenesulfonyl)-2-methyl-4-[(...)
Affinity DataEC50:  2nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271112(7-(2-fluoro-4-methoxybenzenesulfonyl)-2-methyl-4-[...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271160(7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2S)-2-(tr...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271175(4-[(2,2-dimethyloxan-3-yl)oxy]-7-(2-fluorobenzenes...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271172(7-(2-fluoro-4-methoxybenzenesulfonyl)-2-methyl-4-[...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271171(7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2R)-2-(tr...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271088(4-cyclopentyl-7-(3-fluorobenzenesulfonyl)-2-methyl...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271183(7-(2-fluorobenzenesulfonyl)-2-methyl-4-[2-methyl-2...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271166(7-(2,6-difluorobenzenesulfonyl)-4-(2,2-dimethylmor...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270890(7-(benzenesulfonyl)-4-(piperidin-1-yl)-5H-pyrrolo[...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271146(7-(3-fluorobenzenesulfonyl)-4-(2-methylmorpholin-4...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271113(4-[(2R,5R)-2,5-dimethylmorpholin-4-yl]-7-(2-fluoro...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271159(7-(4-chloro-2-fluorobenzenesulfonyl)-4-(2,2-dimeth...)
Affinity DataEC50:  4nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271174(7-(2,6-Difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...)
Affinity DataEC50:  4nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271077(7-(benzenesulfonyl)-4-(2-ethylthiomorpholin-4-yl)-...)
Affinity DataEC50:  4nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271147(7-(2-fluoro-5-methoxybenzenesulfonyl)-2-methyl-4-(...)
Affinity DataEC50:  4nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271142(7-(2,6-difluorobenzenesulfonyl)-2-methyl-4-(2-meth...)
Affinity DataEC50:  5nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271155(7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(1,1,1-tri...)
Affinity DataEC50:  5nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271067(7-(benzenesulfonyl)-4-N-ethyl-4-N-(oxan-4-ylmethyl...)
Affinity DataEC50:  5nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271178(7-(2-fluorobenzenesulfonyl)-4-[(2R)-2-(fluoromethy...)
Affinity DataEC50:  5nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271143(7-(2,4-difluorobenzenesulfonyl)-2-methyl-4-(2-meth...)
Affinity DataEC50:  6nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271062(4-(4,4-difluoropiperidin-1-yl)-7-(3-fluorobenzenes...)
Affinity DataEC50:  6nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271158(3-(benzenesulfonyl)-7-(2,2-dimethylmorpholin-4-yl)...)
Affinity DataEC50:  6nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271057(7-(2-fluorobenzenesulfonyl)-2-methyl-4-{6-oxa-9-az...)
Affinity DataEC50:  6nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271020(7-(benzenesulfonyl)-4-[(2R,6S)-2,6-dimethylmorphol...)
Affinity DataEC50:  6nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271065(7-(benzenesulfonyl)-4-[2-(propan-2-yl)morpholin-4-...)
Affinity DataEC50:  6nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271097(7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2S)-2-met...)
Affinity DataEC50:  6nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271109(7-(benzenesulfonyl)-4-(1-cyclopropylethoxy)-2-meth...)
Affinity DataEC50:  7nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271103(7-(2-fluorobenzenesulfonyl)-2-methyl-4-(prop-1-en-...)
Affinity DataEC50:  7nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271085(US10059713, Example 206)
Affinity DataEC50:  7nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271075(7-(benzenesulfonyl)-4-(2-methylthiomorpholin-4-yl)...)
Affinity DataEC50:  8nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271154(4-[(RS,SR)-2,3-dimethylmorpholin-4-yl]-7-(2-fluoro...)
Affinity DataEC50:  8nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271056(US10059713, Example 175)
Affinity DataEC50:  8nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271168(7-(2,5-difluorobenzenesulfonyl)-4-(2,2-dimethylmor...)
Affinity DataEC50:  8nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 2(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM271151(7-(2-fluorobenzenesulfonyl)-2-methyl-4-(propan-2-y...)
Affinity DataEC50:  8nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

Displayed 1 to 50 (of 1730 total ) | Next | Last >>
Jump to: